HMGB1 and cancer: Knockdown of HMGB1 in nasopharyngeal carcinoma cells inhibits the activation of the HMGB1/RAGE pathway, downregulating the expression of p-ERK1/2 and reducing the migration and invasion capabilities of cancer cells (93).